Enducef T 1000mg/125mg Injection
Marketer
Endurance Healthcare Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Enducef T 1000mg/125mg Injection
Cefixime and Sulbactam injection (1000mg/125mg), marketed as Enducef T, combats bacterial infections by inhibiting microbial growth and proliferation. Administration requires strict medical oversight; consistent adherence to the prescribed dosage schedule is crucial for optimal efficacy. Premature cessation may compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, itching, swelling, respiratory distress) demand prompt medical help. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration are recommended for faster recovery. Your doctor might order lab tests to monitor treatment response.
Primary Ingredients of Enducef T 1000mg/125mg Injection
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Enducef T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Enducef T 1000mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not permitted.
Common Side effects of Enducef T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Enducef T 1000mg/125mg Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strictly prohibited.
How Enducef T 1000mg/125mg Injection works:
The injectable formulation Enducef T (1000mg/125mg) unites ceftriaxone, a bacterial growth inhibitor, with tazobactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thereby hindering bacterial survival. Tazobactam complements this by countering bacterial resistance mechanisms, thus bolstering ceftriaxone's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Enducef T 1000mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Enducef T (1000mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are currently scarce.
Breast feedingCAUTION
The administration of Enducef T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Enducef T 1000mg/125mg Injection can lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Enducef T 1000mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The use of Enducef T 1000mg/125mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Altering the dose of Enducef T 1000mg/125mg Injection is not advised for those experiencing mild or moderate liver dysfunction.
What if you forget to take Enducef T 1000mg/125mg Injection :
Should you inadvertently omit a dose of Enducef T 1000mg/125mg Injection, seek medical advice from your physician.
Facts to Know About Enducef T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently